In today's Psychedelic Spotlight episode, we see David Flores and Riley Cote discuss psychedelics and healing trauma. Riley Cote is a former NHL enforcer and is currently an advocate of plant medicines and psychedelics.
00:00- Intro and Cannabis 3.0
2:03- Riley Cote's experience with trauma, addiction, mental health, and healing with psychedelics
4:34- Addressing trauma in society with plant medicines and psychedelics
7:04- Men being vulnerable, honest with themselves, and sharing their emotions
8:55- Cote's work with Wake: Treating trauma with psilocybin
After years of fighting in the NHL, Cote was dealing with addiction, PTSD, and head trauma issues. Upon leaving the NHL, Cote realized that cannabis and psilocybin helped him heal.
Importantly, once he used psilocybin with intention, he began to become a better person. He was an ego-centric athlete in the past, and psychedelics and plant medicine helped jump-start his spiritual practices such as meditation.
He now teaches nutrition and yoga, which would have never happened if he didn't discover psilocybin.
When he was still fighting in the NHL, he would often feel major stress knowing that he would have to be involved in violent combat that night. Now, he realizes that everyone has trauma, and he wants to help address this with honest conversations.
Psilocybin is still very misunderstood, and Cote is making it his mission to change the conversation. In part through his collaboration with Wake, Cote is working on treating concussions and Traumatic Brain Injury with psilocybin
“Taking the leap” on Plant Medicines and Psilocybin with Formed NHL Enforcer Riley Cote
#Psychedelics #Psilocybin #RileyCote
Have you heard about our new community?
We’re excited to announce Bonfire -
a personal growth community for people who are interested in psychedelics.
Join us for our launch event on July 18th, where we’ll share about the work we’ll be doing together to actualize our personal missions, grow, and heal together.
Psychedelic Spotlight is your reliable source for the latest stories in the emerging psychedelics industry, covering breakthrough discoveries, investor news and cultural reform.